Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein

Environmental Health Perspectives

Volumn 105, Issue 8, 1997, Pages 812-818

  Bain, Lisa J ^a   McLachlan, James B ^a   LeBlanc, Gerald A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Multidrug resistance; Multixenobiotic resistance; P glycoprotein; Pesticides; Structure activity relationships

Indexed keywords

GLYCOPROTEIN P; LIGAND; PESTICIDE; XENOBIOTIC AGENT;

ARTICLE; HYDROGEN BOND; LIPOPHILICITY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030668258     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105812     Document Type: Article

References (35)

1. Gottesman MM, Currier S, Bruggemann E, Lelong I, Stein W, Pastan I. The multidrug transporter: mechanistic considerations. In: Cell Biology and Membrane Transport Processes, Vol 41 (Caplan M, ed). San Diego, CA:Academic Press, 1994;3-17.
2. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738 (1987).
3. Horton JK, Thimmaiah KN, Houghton JA, Horowitz ME, Houghton PJ. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts. Biochem Pharmacol 38:1727-1736 (1989).
4. van Kalken CK, Broxterman HJ, Pinedo HM, Feller N, Dekker H, Lankelma J, Giaccone G. Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer 67:284-289 (1993).
5. Wolf DC, Horowitz SB. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid. Int J Cancer 52:141-146 (1992).
6. Ueda K, Okamura N, Hirai M, Tanigarwara Y, Saeki T, Kioka N, Komano T, Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248-24252 (1992).
7. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased senstivity to drugs. Cell 77:491-502 (1994).
8. Didier AD, Loor F. Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors. Int J Cancer 63:263-267 (1995).
9. Lanning CL, Fine RL, Sachs CW, Rao US, Corcoran JJ, Abou-Donia MB. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein. J Toxicol Environ Health 47:395-407 (1996).
10. Tew KD, Houghton PJ, Houghton JA. Preclinical and Clinical Modulation of Anticancer Drugs. Boca Raton, FL:CRC Press, 1993.
11. 1. Hofsli E, Nissen-Meyer J. Reversal of multidrug resistance by lipophilic drugs. Cancer Res 50:3997-4002 (1990).
12. Bain LJ, LeBlanc GA. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Toxicol Appl Pharmacol 141:288-298 (1996).
13. Bielder JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro; cross-resistance, radioautotrophic, and cytogenic studies. Cancer Res 30:106-110 (1970).
14. Christensen JG, LeBlanc GA. Reversal of multidrug resistance in vivo by oral administration of the phytochemical indole-3-carbinol. Cancer Res 56:574-581 (1996).
15. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemia cells. Mol Pharmacol 33:454-462 (1988).
16. Tsuruo T, Ogawa M, eds. Drug Resistance as a Biochemical Target in Cancer Chemotherapy. San Diego, CA:Academic Press, 1992.
17. Kumar R. Simultaneous determination of some organophosphorus pesticides by high performance liquid chromatography. Biomed Chromatogr 3:272-273 (1989).
18. Rice LG. Rapid separation of pesticides by high-performance liquid chromatography with 3-μM columns. J Chromatogr 317:523-526 (1984).
19. Negre M, Gennari M, Cignetti A. High-performance liquid chromatographic determination of Fluazifop-butyl and Fluazifop in soil and water. J Chromatogr 387:541-545 (1987).
20. van Lancker MA, Bellemans LA, de Leenheer AP. Quantitative determination of low concentrations of adriamycin in plasma and cell cultures, using a volatile extraction buffer. J Chromatogr 374:415-420 (1986).
21. Debal V, Morjani H, Millot J-M, Angiboust J-F, Gourdier B, Manfait M. Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography. J Chromatogr 581:93-99 (1992).
22. Egorin MJ, Hildebrand RC, Cimino EF, Bachur NR. Cytofluorescence localization of adriamycin and daunorubicin. Cancer Res 40:2243-2245 (1974).
23. Hamilton MA, Russo RC, Thurston RV. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Environ Sci Technol 11:714-719 (1978).
24. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972 (1981).
25. Gottesman MM, Patsan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62:385-427 (1993).
26. Phang JM, Poore CM, Lopaczynska J, Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53:5977-5981 (1993).
27. Yeh GC, Lopaczynska J, Poore CM, Phang JM. A new functional role for P-glycoprotein: efflux pump for benzo[a]pyrene in human breast cancer MCF-7 cells. Cancer Res 52:6692-6695 (1992).
28. Ichikawa-Haraguchi M, Sumizawa T, Yoshimura A, Furukawa T, Hiramoto S, Sugita M, Akiyama S. Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland. Biochim Biophys Acta 1158:201-208 (1993).
29. Hodgson E, Levi P. Introduction to Biochemical Toxicology. Norwalk, CT:Appleton & Lange, 1994.
30. Wilson JD, Foster DW. Textbook of Endocrinology. Philadelphia, PA:WB Saunders, 1985.
31. Oude Elferink RPJ, Jansen PLM. The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 64:77-97 (1994).
32. Paul S, Breuninger LM, Kruh GD. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells. Biochemistry 35:14003-14011 (1996).
33. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-462 (1993).
34. Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 42:327-353 (1990).
35. Hontela A. Endocrine and physicological responses of fish to xenobiotics: role of glucocorticosteroid hormones. Rev Toxicol (in press).